Redoubling efforts to highlight the importance of colorectal cancer screening

With the arrival of March, Colorectal Cancer Awareness Month, faculty and staff in the Department of Internal Medicine's Section of Digestive Diseases are redoubling their efforts to spread the word about the importance of screening, especially in younger individuals and those with a family history of the disease.

Colorectal cancer is the second most common cause of cancer death in the United States. Still, many people are unaware of the role screening plays in reducing their risk of developing the disease.

"Caught early, this cancer has an excellent prognosis, and screening has been shown to decrease incidence and mortality," said Xavier Llor, MD, PhD, professor of medicine (digestive diseases), Yale School of Medicine; medical director of the Cancer Screening and Prevention Program and Colorectal Cancer Prevention Program at Smilow Cancer Hospital and Yale Cancer Center.

Despite the continued overall decline of colorectal cancer, recent statistics are worrisome, Llor said. According to the latest report from the American Cancer Society, the proportion of cases among those younger than 55 has increased and the progress against colorectal cancer as a whole has slowed.

Llor recommends that health care providers start the discussion with patients by age 40, to increase the chances that they will get screened by 45. Individuals with a parent, sibling, or child who had colorectal cancer should start screening earlier, at age 40, he said.

It takes time and repeated reminders for many people to finally have a colorectal cancer screening done. If we promote awareness together, with the help of general practitioners, we can make a difference."

Xavier Llor, MD, PhD, professor of medicine (digestive diseases), Yale School of Medicine

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients